Navigation Links
Global Network for Neglected Tropical Diseases Partners with IDB, PAHO to Control and Eliminate Neglected Tropical Diseases in Latin America, Caribbean
Date:9/8/2009

Global Network, at the Sabin Vaccine Institute, Provides $2.5 Million Grant to Establish a Financing Mechanism to Immediately Begin Supporting NTD Programs in the Region; Marks First Financing Partnership Developed Under Gates Foundation Grant

Washington, DC (PRWEB) September 8, 2009 -- The Global Network for Neglected Tropical Diseases announced today that it is partnering with the Inter-American Development Bank (IDB) and the Pan American Health Organization (PAHO) to launch a major effort to fight neglected tropical diseases (NTDs) plaguing more than 200 million people in Latin America and the Caribbean. To help launch this effort, the Global Network provided a $2.5 million grant to establish a financing mechanism that will immediately begin supporting NTD programs in the region.

"We are proud to be part of this extraordinary partnership to help control and eventually eliminate some of these devastating diseases from the region," said Kari Stoever, Managing Director of the Global Network. "This new partnership is the first milestone reached in developing Regional Funds under the generous Gates Foundation grant awarded to the Global Network to foster collaboration to defeat neglected tropical diseases. It also is a concrete example of how organizations and governments can work together to support new investments to reach control and elimination goals under President Obama's Global Health Initiative."

The new Regional Fund will support measures to control and eliminate NTDs, the most common infections of more than 200 million of the poorest people in the Latin American and Caribbean region. They include tens of millions of cases of intestinal worm infections, such as whipworm, large common roundworm, and hookworm, and almost 10 million cases of Chagas disease, as well as schistosomiasis, trachoma, dengue fever, leishmaniasis, lymphatic filariasis (LF), and onchocerciasis.

NTDs produce extreme poverty through their impact on children's physical and cognitive development, pregnancy outcome and worker productivity. However, with a firm commitment from the public and private sectors, it is possible to eliminate onchocerciasis, lymphatic filariasis and trachoma throughout the region as well as schistosomiasis in the Caribbean.

Ultimately, the roadmap for the control and elimination of the more widespread NTDs will require an inter-sectoral approach that bridges public health, social services, and environmental interventions. The IDB has been a leader in championing this approach through its efforts to create new linkages between water and sanitation projects and public health programs.

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2844964.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Global Financial Crisis a Key Driver in Market Conditions for Property, Casualty, and Directors and Officers Lines, Says Aon
2. Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma
3. SYGNIS to Present at the 11th Rodman & Renshaw Annual Global Investment Conference
4. Reportlinker Adds Liver Disease Treatments: The Global Market Report
5. Reportlinker Adds Anti-aging Products and Services: The Global Market Report
6. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
7. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
8. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
9. ALPHARx to Present at Rodman Renshaw Annual Global Investment Conference
10. Echo Therapeutics to Present at Rodman & Renshaw 2009 Annual Global Investment Conference
11. Hologic to Present at the 2009 Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... a breakthrough topical cream that’s the first in a new class of photodynamic ... the overall appearance of skin, visibly reduce outward signs of aging, and minimize ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... rely on contracted partners to help with process innovation in drug formulation and ... formulation experience along with state-of-the-art analytical equipment in support of their development and ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing ... advance their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered ... few as 16 months and for as little as $14,528. These changes will enable ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... India , April 19, 2017 ... and Application, Forecast to 2022 report has covered and analysed ... statistics and information on market size, shares and growth factors. ... major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
Breaking Medicine Technology: